The Silent Progression of Alzheimer’s
Alzheimer’s is not simply a disease of memory—it affects individuals, families, and communities. Yet diagnosis often happens only after symptoms become obvious, when treatment options are limited and the emotional and financial toll is greatest.
Why late diagnosis hurts
-
Lost time for planning and treatment
-
Increased stress on families and caregivers
-
Higher long-term costs and fewer options
A Growing Global Crisis
People are living with dementia worldwide; ~10 million new cases each year (≈1 every 3 seconds)
Americans aged 65+ are living with Alzheimer’s today; the number is projected to double by 2060
Estimated global cost of dementia care annually; $300B+ in the U.S. alone
MemorAmp Shifts the Timeline— and the Outcome
MemorAmp’s Pivot detects Alzheimer’s biomarkers in saliva —non-invasive, fast, and accessible. Instead of waiting for memory loss, families and doctors gain the power of early knowledge.
Early, non-invasive
Saliva sample—no clinic visit required
Ultra-sensitive
Graphene biosensors with DNA aptamers detect biomarkers at very low levels
Actionable results
Clear report in minutes, shareable with clinicians
MemorAmp Shifts the Timeline—and the Outcome
MemorAmp’s Pivot detects Alzheimer’s biomarkers in saliva —non-invasive, fast, and accessible. Families and doctors gain the power of early knowledge.
More time with loved ones before memory loss
Better chance to join clinical trials and benefit from new therapies
Clarity and peace of mind for families to prepare financially and emotionally